INVESTIGADORES
TARAVINI Irene Rita Eloisa
congresos y reuniones científicas
Título:
Motor temporal patterns and stereotypies but not rotational behavior can better explain motor response complications in Parkinson's disease.
Autor/es:
DELFINO MA; STEFANO AV; FERRARIO JE; TARAVINI IR; MURER MG; GERSHANIK OS
Lugar:
Miami, Florida, USA
Reunión:
Congreso; 7th International Congress of Parkinson's Disease and Movement Disorders; 2002
Institución organizadora:
The Movement Disorder Society
Resumen:
Objetives: To evaluate an
experimental paradigm that could be used to challenge the hypothesis that
rotational behavior is an indicator of L-dopa-induced dyskinesias.
Background: Repeated treatment
with dopamine agonists strongly potentiates contralateral turning behavior in
response to D1 and D2 agonist in unilaterally 6-hydroxydopamine
(6-OHDA)-lesioned rats in the middle forebrain bundle (MFB). This sensitization
is believed to be related to motor
response complications (dyskinesias, on-off states) that occur during chronic
administration of L-DOPA in Parkinson's disease (PD) patients. Most authors
conclude that the observed enhancement in rotational response after repeated
L-Dopa or Apomorphine (Apo) administration is the experimental equivalent of
L-Dopa induced dyskinesia (LID) seen in PD patients. However, there is evidence
that 6-OHDA lesioned rats treated for 6 months with L-Dopa do not show a
sensitized response, in terms of rotational behavior, to apomorphine
injections, as it would have been expected. Moreover, given the rich repertoire
of behaviors exhibited by rodents it is probably that they could display
movements comparatively similar to the abnormal involuntary movements seen in PD
patients under chronic L-Dopa treatment..
Methods: Animals were lesioned
with 6-OHDA in the MFB. Two weeks later a cylinder test (% akinesia of the
lesioned paw) was performed for the selection of the denervated animals.
Animals were divided into three groups, one was primed with Apo, the second
with quinpirole (Qp) and the third with vehicle; a month later treatment with
Qp or Apo (for three weeks) was started and
rotational behavior was observed and an abnormal involuntary movement test
(AIM) was performed for two hours in each behavioral session.
Inmunohistochemistry for c-fos was done in order to obtain a biochemical
correlation.
Results: We found that
stereotypies and motor temporal patterns best distinguished between the
different treatment regimes, while enhancement in rotational behavior did not
differ significantly across groups. Selective increase in contralateral forepaw
dyskinesia was highly expressed in Apo-Apo treated animals, followed by Apo-Qp,
Qp-Qp, and vehicle. In addition the slope of the curve representing changes in
rotation along time also showed differences between groups.
Conclusion: We believe this simple evaluation
paradigm could be used to differentiate drugs less prone to induce motor
complications in Parkinson's Disease and provide an insight into their
pathophysiology.